1301 - CNI-free GVHD (PROGRESS II)

Go Back to BMT CTN Protocol Listing

  • Protocol Short Name and Number: CNI-free GVHD (PROGRES II), 1301
  • Protocol Long Name: A Randomized, Multi-Center, Phase III Trial of Calcineurin Inhibitor-Free Interventions for Prevention of Graft-versus-Host Disease
  • Protocol (PDF)
  • ICFs (PDF)
  • FAQs (PDF)
  • Key Personnel
    • BMT CTN # 1301 Co-Chair: Miguel-Angel Perales, MD
    • BMT CTN # 1301 Co-Chair: Leo Luznik, MD
    • BMT CTN # 1301 Protocol Officer: Marcelo Pasquini, MD, MS
    • BMT CTN # 1301 Protocol Coordinator: Kristy Applegate, MBA; bmtctn1301@emmes.com
  • Keywords: Allo Transplant, Allogeneic Transplant, Allo, Unrelated, Unrelated Donor, HSCT, HCT, Graft versus Host Disease, GVHD, Graft vs. Host Disease, Prophylaxis, Quality of Life, QOL, Calcineurin Inhibitor-Free, CNI, Tacrolimus, TAC, Methotrexate, MTX, Acute Leukemia, Myelodysplastic Syndrome, MDS, Chronic Myelomonocytic Leukemia, CMML, Leukemia, PROGRESS, CliniMACS, Pediatric, Child, Children, Teen, Adolescent